Mirum Pharmaceuticals, Inc.· MIRM

🇺🇸 US · MidBroad USNASDAQ

HealthcareBiotechnologyWebsite

Price: $104.33
Day: -0.25%
Mkt Cap: $6.36B
52W Range: $50.25 – $130.00
Volume: 569.4K
Beta: 0.51

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Blog

stockoscope.com

Mirum Pharmaceuticals, Inc.

MIRM|Healthcare|Biotechnology

Comparing against 140 sector peers in United States · Mid Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

83%ile

50.2%

Operating Margin

13%ile

-12.3%

ROIC

30%ile

-11.3%

FCF Yield

34%ile

-2.7%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

1926.8%

EBIT Growth

1177.0%

Net Income Growth

932.9%

OCF Growth

2396.7%

FCF Growth

519.1%

Income Quality

0.21

Returns on Capital (TTM)

ROE(-289.3%)

2%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROCE(-11.3%)

30%ile

Below Avg

PoorWeakAdequateStrongExceptional

ROA(-89.7%)

2%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROIC(-11.3%)

30%ile

Below Avg

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(81.4%)

83%ile

Top 20%

PoorWeakAdequateStrongExceptional

EBITDA Margin(-133.6%)

2%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Operating Margin(-12.3%)

13%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Net Margin(-140.2%)

3%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

3%ile

-0.05

Debt/Capital

3%ile

-0.06

Net Debt/EBITDA

100%ile

0.00

Interest Coverage

23%ile

-4.87x

Liquidity (TTM)

Current Ratio

24%ile

2.09

Quick Ratio

27%ile

1.99

Cash Ratio

47%ile

1.19

WC Turnover

63%ile

1.78

Operational Efficiency (TTM)

Asset Turnover

60%ile

0.64

DSO

15%ile

85.3

Days Inventory

24%ile

87.7

Cash Conv. Cycle

86%ile

-31.2

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore MIRM on stockoscope.com→

Generated August 5, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

140 sector peers (United States · Mid Cap · Healthcare)

Relative Quality

MIRM Relative Quality Score

Ranked against 140 sector peers in United States · Mid Cap · Healthcare

Relative Quality

2.7/5

Adequate

vs 140 sector peers

Peer Rankings (9 of 10 available)

Relative Quality Score of 2.70/5 (Adequate) based on percentile rankings against 140 sector peers in United States · Mid Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated August 5, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

Revenue Growth

83rd percentile, Exceptional

Value: 50.19%
Percentile: 83%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

MIRM has a ttm revenue growth of 50.19% and ranks at the 83rd percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Margin Efficiency

Does the company maintain better profit margins than peers?

Gross Margin

83rd percentile, Exceptional

Value: 81.36%
Percentile: 83%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

MIRM has a ttm gross margin of 81.36% and ranks at the 83rd percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

60th percentile, Adequate

Value: 0.64
Percentile: 60%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

MIRM has a ttm asset turnover of 0.64 and ranks at the 60th percentile vs United States · Healthcare sector peers. Adequate financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

ROA

2nd percentile, Poor

Value: -89.67%
Percentile: 2%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

MIRM has a ttm roa of -89.67% and ranks at the 2nd percentile vs United States · Healthcare sector peers. Poor financial performance.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

100th percentile, Exceptional

Value: 2396.71%
Percentile: 100%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

MIRM has a ttm operating cash flow growth of 2396.71% and ranks at the 100th percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

47th percentile, Adequate

Value: 1.19
Percentile: 47%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

MIRM has a ttm cash ratio of 1.19 and ranks at the 47th percentile vs United States · Healthcare sector peers. Adequate financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

3rd percentile, Poor

Value: -0.06
Percentile: 3%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

MIRM has a ttm debt-to-capital of -0.06 and ranks at the 3rd percentile vs United States · Healthcare sector peers. Poor financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -7.66
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank MIRM for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

No data for Dividend Yield is available for MIRM, so peer comparison is hidden for this metric. Try another metric.

Peer companies

The 140 companies MIRM is compared against across its sector and industry cohorts.

Mirum Pharmaceuticals, Inc.· MIRM

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies